Navigation Links
difficulty in Biological Technology

KV Pharmaceutical Announces Stockholder Action to Amend By-Laws is Invalid

... rates and capital and consumer spending; (3) the difficulty of predicting FDA approvals, including timing, ... (11) fluctuations in revenues; (12) the difficulty of predicting international regulatory approvals, including timing; (13) the difficulty of predicting the pattern of inventory movements ...

Intra-Cellular Therapies Reports Positive Final Results of a Phase II Clinical Trial with ITI-007 in Patients with Sleep Maintenance Insomnia

... for the treatment of insomnia characterized by difficulty in staying asleep, as well as for the treatment ... elderly and those with comorbid conditions, have difficulty staying asleep throughout the night," said Thomas ... for the treatment of insomnia characterized by difficulty staying asleep, also referred to as sleep ...

KV Pharmaceutical Enters Into Consent Decree With FDA

... rates and capital and consumer spending; (2) the difficulty of predicting FDA approvals, including timing, ... (9) fluctuations in revenues; (10) the difficulty of predicting international regulatory approval, including timing; (11) the difficulty of predicting the pattern of inventory movements ...

Transcept Pharmaceuticals Announces FDA Acceptance for Review of New Drug Application for Intermezzo(R)

... a middle of the night awakening is followed by difficulty returning to sleep. Glenn A. Oclassen, ... middle of the night when patients awaken and have difficulty returning to sleep. Based on an anticipated ... they awakened in the middle of the night and had difficulty returning to sleep. This Phase 3 clinical trial ...

Celebrity Designer Ty Pennington to Host 10th Annual 'ADHD Experts on Call' Program

... with ADHD may seem easily distracted or have difficulty sitting still, adults may have ADHD symptoms that appear as having difficulty finishing tasks or seeming impatient. 'ADHD ... of Vyvanse were: children -- decreased appetite, difficulty falling asleep, stomachache, and irritability; ...

ETHEX Corporation Voluntarily Recalls Specific Lots of 30 mg. and 60 mg. Morphine Sulfate Extended Release Tablets Due to the Potential for Oversized Tablets

... and capital and consumer spending; (2) the difficulty of predicting FDA approvals, including timing, ... (9) fluctuations in revenues; (10) the difficulty of predicting international regulatory approval, including timing; (11) the difficulty of predicting the pattern of inventory movements ...

KV Pharmaceutical Company Comments on Legal Development in Its Branded Pharmaceutical Business

... and capital and consumer spending; (2) the difficulty of predicting FDA approvals, including timing, ... (9) fluctuations in revenues; (10) the difficulty of predicting international regulatory approval, including timing; (11) the difficulty of predicting the pattern of inventory movements ...

KV Pharmaceutical Company Announces Approval for the 50 mg Strength of Generic Version of Toprol-XL(R)

... and capital and consumer spending; (2) the difficulty of predicting FDA approvals, including timing, ... (9) fluctuations in revenues; (10) the difficulty of predicting international regulatory approval, including timing; (11) the difficulty of predicting the pattern of inventory movements ...

FDA Approves VYVANSE(TM) (lisdexamfetamine dimesylate), the First and Only Once-Daily Prodrug Stimulant to Treat ADHD in Adults

... events in this study were decreased appetite, difficulty falling asleep, and dry mouth. About ADHD ... of VYVANSE were: children - decreased appetite, difficulty falling asleep, stomachache, and irritability; adult - decreased appetite, difficulty falling asleep, and dry mouth. Aggression, new ...

KV Pharmaceutical Company Reports Record Revenues for Fiscal 2008 Second Quarter and Six Months on a Preliminary Basis

... and capital and consumer spending; (2) the difficulty of predicting FDA approvals, including timing, ... (9) fluctuations in revenues; (10) the difficulty of predicting international regulatory approval, including timing; (11) the difficulty of predicting the pattern of inventory movements ...

Purdue Pharmaceutical Products L.P. and Transcept Pharmaceuticals, Inc. Sign Exclusive Agreement to Commercialize Intermezzo(R) in the United States

... for use in the middle of the night at the time a patient awakens and has difficulty returning to sleep. The FDA has established October 30, 2009 as the ... for use in the middle of the night at the time a patient awakens and has difficulty returning to sleep. Intermezzo ((R)) is a sublingual low dose ...

Study Published in Child and Adolescent Psychiatry and Mental Health Demonstrated Once-Daily Vyvanse(R) (lisdexamfetamine dimesylate) CII Provided Significant Improvement of ADHD Symptoms for Children at 13 Hours After Administration

... reported in studies of Vyvanse were: children - decreased appetite, difficulty falling asleep, stomachache, and irritability; adult - decreased appetite, difficulty falling asleep, and dry mouth. Aggression, new abnormal ...

Study Showed VYVANSE(R) (lisdexamfetamine dimesylate) CII Provided Significant Efficacy at 14 Hours After Administration in Adults with ADHD in an Adult Simulated Workplace Environment

... reported in studies of Vyvanse were: children - decreased appetite, difficulty falling asleep, stomachache, and irritability; adult - decreased appetite, difficulty falling asleep, and dry mouth. Aggression, new abnormal ...

FDA Approves Labeling Change for VYVANSE(R) (lisdexamfetamine dimesylate) CII to Include Supplementary Clinical Data Supporting Efficacy at 13 Hours Postdose in Children Aged 6 to 12 with ADHD

... reported in studies of Vyvanse were: children - decreased appetite, difficulty falling asleep, stomachache, and irritability; adult - decreased appetite, difficulty falling asleep, and dry mouth. Aggression, new abnormal ...

New rotors could help develop nanoscale generators

... an important part in machines like electric motors and generators. The difficulty for technology at the atomic scale is to replicate this property with ... Werner Hofer, from the University's School of Chemistry, explains: "The difficulty in creating molecular rotors is that molecules need a fixed anchor point ...

Shire and GlaxoSmithKline Enter Agreement to Co-promote VYVANSE(R) (lisdexamfetamine dimesylate) CII for the Treatment of Adults With ADHD

... reported in studies of VYVANSE were: children - decreased appetite, difficulty falling asleep, stomachache, and irritability; adult - decreased appetite, difficulty falling asleep, and dry mouth. Aggression, new abnormal ...

The MedZilla Report: Febraury 2009 Employment Outlook for Biotech/Pharma/Health

... care job cuts that were announced were mostly due to the overall economic difficulty facing the United States. (Vocus) March 30, ... Journal, February 25, 2009) Hopps said that these companies often see difficulty due to the need to specialize. "They develop drugs that might fail in ...

Video: Allergan Announces U.S. Food and Drug Administration (FDA) Approval of Latisse(TM) -- First and Only Treatment Approved by the FDA for Hypotrichosis of Eyelashes

... If you think you're having an allergic reaction or other reaction, such as difficulty swallowing, speaking, or breathing, call your doctor immediately. ... dystonia, the most common side effects following injection include difficulty swallowing (19%), upper respiratory infection (12%), neck pain (11%), and ...

Alexza Reports 2008 First Quarter Financial Results and Updates Development of Product Candidates

... developing AZ-007 for the treatment of insomnia in patients who have difficulty falling asleep, including patients who awake in the middle of the night and have difficulty falling back asleep. In March 2008, Alexza completed enrollment in a ...

Edwards Lifesciences Reports Strong First Quarter Results and Raises 2008 Guidance

... special items and foreign exchange fluctuations due to the inherent difficulty in forecasting such items. By disclosing non-GAAP financial measures, ... special items and foreign exchange fluctuations due to the inherent difficulty in forecasting such items. By disclosing non-GAAP financial measures, ...

In response to a New England Journal of Medicine article published yesterday and subsequent media coverage, Eli Lilly and Company issued the following statement:

... hydrochloride. Some people experience side effects like nausea, difficulty sleeping, drowsiness, anxiety, nervousness, weakness, loss of appetite, ... families should watch for these as well as for anxiety, agitation, panic, difficulty sleeping, irritability, hostility, aggressiveness, impulsivity, ...

Angiotech Pharmaceuticals announces launch of Quill SRS product codes for laparoscopic gynecology procedures

... and other novel elements of Angiotech's Quill SRS for laparoscopic and robotic-assisted surgery are expected to significantly reduce the time and difficulty of completing a wound closure in these types of surgical procedures, where tying sutures through small incisions using instruments, while having ...

Rapid heating prepares energy-saving zeolite for greater role in industrial separations

... their full industrial potential. These include high processing costs; scalability, or the ability to make zeolite membranes in large area; and the difficulty in controlling grain boundary defects, or non-selective pathways at the crystal grain interfaces, which cause poor separation performance. ...

Health Robotics to Launch Germany's Installations of i.v.STATION(TM) at Charite-Universitatsmedizin Berlin

... are serious medication errors, high costs, turn-around time, waste, regulatory issues, lack of audit trails, motion injuries, space constraints and difficulty in maintaining adequate and trained clinical staff. The i.v.STATION robot that automatically compounds non-hazardous IV doses and delivers them to ...

New statistical technique improves precision of nanotechnology data

... techniques for quantitative analysis of data from nanomechanical measurements. Nanotechnology researchers have long been troubled by the difficulty of measuring nanoscale properties and separating signals from noise and data artifacts. Data artifacts can be caused by such issues as the slippage ...

Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa

... and Embryology (ESHRE) in Amsterdam, The Netherlands. "The burden of fertility treatment is a major challenge for women experiencing difficulty conceiving," said Thomas Koestler, executive vice president and president, Schering-Plough Research Institute. "Schering-Plough is committed to ...

Celsis Outlines the Top Five Advantages of Cryo-plateable Hepatocytes

... screening (HCS). In summary, the uncertainties associated with fresh hepatocytes - lack of availability of donors, difficulty matching profiles, unknown enzymatic activities, inability to repeat experiments from the same donor and time restrictions - often mean researchers ...

AEterna Zentaris to Report Data from Safety Study of Phase 3 Program in Benign Prostatic Hyperplasia with Cetrorelix Ahead of Schedule

... LUTS. BPH is associated with LUTS, including: frequent urination, a sudden, uncontrollable urge to urinate, waking at night to urinate (nocturia), difficulty starting a urine stream (hesitancy and straining), decreased strength of the urine stream (weak flow), feeling that the bladder is not completely ...

AEterna Zentaris Opens Extended Study for Cetrorelix in Benign Prostatic Hyperplasia

... LUTS. BPH is associated with LUTS, including: frequent urination, a sudden, uncontrollable urge to urinate, waking at night to urinate (nocturia), difficulty starting a urine stream (hesitancy and straining), decreased strength of the urine stream (weak flow), feeling that the bladder is not completely ...

Clinical Pharmacology Study With AZILECT(R) (Rasagiline Tablets) Demonstrated It Does Not Increase Tyramine Sensitivity

... Copaxone(R) sales, the impact of pharmaceutical industry regulation and pending legislation that could affect the pharmaceutical industry, the difficulty of predicting U.S. Food and Drug Administration, European Medicines Agency and other regulatory authority approvals, the regulatory environment and ...

Europium discovery

... only contain one kind of atom," Schilling said. "By applying pressure, however, we can bring the elemental solids into new regimes, where theory has difficulty understanding things. "When we understand the element's behavior in these new regimes, we might be able to duplicate it by combining the elements ...

The Concerned Shareholders of Biovail Say Biovail Has Misled Shareholders

... of their choice. This would have been patently unfair and against proper governance practices. Unfortunately, a technical difficulty beyond the control of the Concerned Shareholders has caused the issue with respect to the unavailability of telephone and internet voting which is a ...

ChemoCentryx Identifies Novel Small Molecule C5aR Antagonist

... of vasculitis, among other diseases. "In the quest to develop medicinally relevant inhibitor compounds, C5a receptor has been a target of epic difficulty in the pharmaceutical industry. CCX168 is a highly potent and specific C5a receptor small molecule antagonist, and unlike other compounds that have ...

Transcept Pharmaceuticals to Present at the Bank of America and Merrill Lynch 2009 Health Care Conference

... (R) will be the first commercially available sleep aid designed specifically for use in the middle of the night when patients awaken and have difficulty returning to sleep. Intermezzo (R) Phase 3 clinical trials have been completed and, on September 30, 2008, Transcept submitted a New Drug ...

NxStage to Report First Quarter 2009 Financial Results

... from those indicated by these forward-looking statements as a result of various important factors including, but not limited to, unexpected difficulty in closing the company's financial books for the quarter and other factors that are discussed in NxStage's Annual Report on Form 10-K for the year ...

Cell Biosciences Announces Publication in Nature Medicine

... from cancer patients. This work was performed using a protein analysis system from Cell Biosciences. "Current protein research methods have difficulty detecting subtle changes in oncoprotein activation, changes that underlie critical cancer signaling processes," explained lead author Dr. Alice Fan. ...

Delaware Court Rules That Watson Does Not Infringe Patent Related to Generic Version of Concerta(R) and Declares Patent Invalid

... from Watson's current expectations depending upon a number of factors affecting Watson's business. These factors include, among others, the difficulty of predicting the timing and outcome of litigation, including the litigation concerning the '373 and '129 Patents; the impact of competitive products ...

Publication of Shire plc's Annual Report 2008

... of rare genetic diseases such as REPLAGAL and ELAPRASE, may be high compared to other pharmaceutical products. The Group may encounter particular difficulty in obtaining satisfactory pricing and reimbursement for its products, including those that are likely to have a high annual cost of therapy. The ...

GYNECARE PROLIFT+M(TM) Pelvic Floor Repair System Launched in US for Use in Pelvic Organ Prolapse Surgery

... All surgical procedures present some risks. Complications associated with surgical treatment for POP include injury to blood vessels of the pelvis, difficulty urinating, pain, scarring, pain with intercourse, bladder and bowel injury. There is also a risk of the mesh material becoming exposed into the ...

Tolerx Expands Phase 3 'DEFEND' Trial of Otelixizumab in Europe

... About Type 1 Diabetes Diabetes (medically known as diabetes mellitus) is the name given to disorders in which the body has difficulty regulating its blood glucose (sugar) level. There are two major types of diabetes: type 1 and type 2. Type 1, previously known as juvenile diabetes ...
Other Contents
(Date:10/18/2014)... suspected genetic conditions, a certain type of exome sequencing ... than traditional molecular diagnostic methods, according to a study ... released to coincide with the American Society of Human ... protein­coding region of the genome (the complete set of ... organism), has been rapidly applied in research settings and ...
(Date:10/17/2014)... release is available in German . ... a very few drugs. When treating overdoses, doctors are often ... especially difficult if there is a combination of drugs involved. ... and accidentally swallows his grandmother,s pills? ETH professor Jean-Christophe Leroux ... to find an answer to this question. "The task was ...
(Date:10/16/2014)... researchers have challenged conventional thinking on how the bowel ... mechanism for how bowel cancer starts. , The researchers ... and regenerating the ,crypts, that are a feature of ... involved in bowel cancer development, a controversial finding as ... , Using 3D imaging technologies, Dr Chin Wee Tan ...
Breaking Biology News(10 mins):Study examines type of exome sequencing and molecular diagnostic yield 2Study examines type of exome sequencing and molecular diagnostic yield 3Emergency aid for overdoses 2Emergency aid for overdoses 3Cryptic clues drive new theory of bowel cancer development 2
(Date:10/20/2014)... Diego, CA (PRWEB) October 20, 2014 AttorneyOne.com, ... all the latest information from the FDA on Sit ... on October 10 not to purchase or use Sit and ... Sit and Slim II is promoted as weight loss product ... Sibutramine, removed from the market in 2010 for safety reasons, ...
(Date:10/20/2014)... Succeed is proud to announce that they ... in the Every Body Walk! campaign by Kaiser ... that encourages workers to be more active outside of the ... concluded at the end of September, was a friendly competition ... areas. Participating companies gave their staff pedometers and each ...
(Date:10/20/2014)... Viejo, California (PRWEB) October 20, 2014 Final ... announced the release of the Citrus theme for FCPX ... I would use to describe the Citrus theme” Says Christina ... so easy to look so professional.” , Citrus comes with ... Included with the template are: four transitions for added style, ...
(Date:10/20/2014)... Punzoné , the first line of ultra-premium ... lot to celebrate this month. October marks Italian Heritage Month ... contributions of Americans of Italian heritage and Italians in America. ... shares its favorite Italian cocktails and encourages everyone to enjoy ... if it is only in a glass. , Punzoné ...
(Date:10/19/2014)... October 20, 2014 Hastings and Hastings, ... years of service throughout the greater Phoenix area and ... representation with regard to catastrophic automobile accidents. Statistics have ... country and throughout Arizona. As such, Hastings and Hastings ... legal representation for those who have been injured through ...
Breaking Medicine News(10 mins):Health News:FDA Advises Not to Use Sit and Slim II: AttorneyOne Monitors and Keeps Consumers Informed 2Health News:Succeed Management Solutions, LLC Competes in Walking Challenge and Achieves 12th Place in Portland 2Health News:Today Pixel Film Studios Announced the Release of the Citrus theme for Final Cut Pro X 2Health News:Celebrate Italian Heritage Month With Authentic Cocktails from Punzoné: The Only Ultra Premium Line of Organic Imported Italian Vodka 2Health News:Celebrate Italian Heritage Month With Authentic Cocktails from Punzoné: The Only Ultra Premium Line of Organic Imported Italian Vodka 3Health News:Celebrate Italian Heritage Month With Authentic Cocktails from Punzoné: The Only Ultra Premium Line of Organic Imported Italian Vodka 4Health News:Hastings And Hastings Reports Record Demand In 2014 For Legal Representation With Regard To Catastrophic Automobile Accidents 2Health News:Hastings And Hastings Reports Record Demand In 2014 For Legal Representation With Regard To Catastrophic Automobile Accidents 3
Other TagsOther Tags